The exploration of natural products for the treatment of malarial has been the main focus of scientists in the past decades. In this research, the phytochemical constituents, antimalarial effect, and chemopreventive capacity of aqueous leaf extract of Bambusa vulgaris in malaria parasitized mice was investigated. A total of 30 male mice, grouped into six (n=5), was used. The results obtained showed that B. vulgaris is rich in flavonoid (262.08 µg CE/g) and phenol (0.91 g AAE/ 100 g). There was significant reduction on the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and Gamma glutarmyl-transferase (GGT) upon treatment as compared with the control groups (P<0.05). Concentration of total bilirubin (TB), direct bilirubin (DB) and serum electrolytes (sodium, calcium, phosphorus and chloride) decreased in treated groups; serum urea, creatinine and uric acid also reduced significantly as against the control groups (P<0.05). The hepatoprotection and renal function restoration observed upon the administration of the plant extract indicate to a far reaching end that B. vulgaris leaf extract would be a promising natural antimalarial product devoid of side effects upon use, especially when administered within the dose range of 100 -200 mg/Kg body weight investigated in this study.
Malarial, a condition that depletes hepatocytes remains the prevailing infectious diseases in Sub-Saharan Africa (WHO, 2016) . Plasmodium falciparum, the deadliest form of the malarial parasite, is responsible for the enormous majority of the mortality and morbidity associated with malarial infection. Artemisinin Combination Therapies (ACTs) are presently the major drugs in the management of malarial caused by P. falciparum. Although these treatments continue to be effective in many parts of the world, the occurrence of the malarial parasite resistance to ACTs, a combatant is an urgent public health concern (WHO, 2016; Wele et al., 2017) . Medicinal plants are being used for the treatment of diseases since inception worldwide (Wele et al., 2017) . Since most of the developing nations have no access to modern therapeutics such as ACT to treat malarial because of financial, geographical and/or cultural impediments, they fall back to the use of medicinal plant for the management of diseases. About 80% population of the world relies on traditional medicinal products for some aspects of primary healthcare (WHO, 2016) . Improved knowledge of plants from traditional pharmacopoeias and validated traditional medications in Improved Traditional Medicine (ITM) can result to access to effective, standardized, ever present with moderate prize therapeutics for management of malarial by local populations (WHO, 2012) . In Africa and other countries where malarial exists, traditional medicinal plants are habitually used as preventive or curative for malarial (Jenett-Siems et al., 1999) . It is true that orthodox antimalarials such as quinine and artemisinin derivatives originated from plants. It is therefore reasonable to investigate the antimalarial activity of medicinal plants in order to define their potential as sources of new antimalarial agents (Mustofa et al., 2007) . Bamboo is a large perennial grass dispersed widely from tropical to subarctic zones (Ambika and Rajagopal, 2017) . In Asian countries, different parts of bamboo have been used for medicinal purposes to treat hypertension, arteriosclerosis, cardiovascular disease and certain forms of cancer, antioxidant activities and are non-toxic (Tanaka et al., 2013) . However, this study focuses on the use of aqueous leaf extracts of Bambusa vulgaris for the treatment of Plasmodium berghei-infected mice. 
MATERIALS AND METHODS

Chemicals and
Preparation of Extract:
The leaves were washed to remove contaminants and air-dried for about three weeks. Thereafter, they were grinded to fine powder using Waren blender. 700g of the powdered form was soaked in 2800ml (2.8L) of distilled water in a ratio 1:4. It was macerated after 48hrs to obtain the crude extract (Anigboro et al., 2018) . This was followed by filtration using Whatman No110 filter paper. The purified crude was then concentrated using a vacuum rotary evaporator at reduced temperature (50 o C) and bathe at 40 o C. This yielded a dark brown concentrated extract of 29g (4.14%w/w). The obtained crude extract was packaged in an airtight plastic container and stored at 4 o C until when required for use.
Inoculation:
The mice were inoculated intraperitoneally with Plasmodium berghei and baseline was established as described by Ambika and Rajagopal (2017) .
Experimental design: A total of thirty (30) mice were used for this experiment. The mice were divided into six (6) groups of five (5) The experiment was lasted for two weeks; thereafter, determination of malarial load and biochemical parameters was undertaken.
Collection of Sample:
The rats were sacrificed by cervical dislocation or decapitation and blood sample was collected using 5ml syringe from each rat. Samples were emptied into anticoagulant containers to prevent clotting (plasma enzymes). Some of the samples were equally placed in universal containers (serum enzymes) assayed biochemically. Phytochemical Screening: Plant materials were subjected to qualitative phytochemical screening to determine the presence of the major phytochemical constituents: alkaloids, glycosides, flavonoids, phlabatannins, phenols, resin, saponins, tannins, triterpenes, steroids, proteins, carbohydrates, amino acids, gums, mucilage, non-reducing polysaccharides and non-reducing simple sugar according to standard methods outlined by Petchi et al. (2013) . Quantitative analysis was carried out to determine the percentage of phenol and flavonoids present in the extract as described by Bharathi et al. (2013) .
Statistical Analysis: The data was analyzed using a computer software (SPSS version 21) and compared using Bonferroni test. The results are represented as Mean ± SD. Mean values compared were considered significantly different at p<0.05.
RESULTS AND DISCUSSION
Malarial, a life threatening disease is known to deplete the levels of red blood cell and eventually cause anemia and loss of life in most cases (WHO, 2016) . The secondary metabolites; alkaloids, glycosides, flavonoids, phlabatannins, phenols, resin, saponins, tannins, triterpenes, steroids, proteins, carbohydrates, amino acids, gums, mucilage, non-reducing polysaccharides and non-reducing simple sugar present were screened qualitatively and the result showed the presence of some highly active phytochemicals in the leaf extract of Bambusa vulgaris such as phenols, flavonoids, saponin etc (Table 1a) . Quantitative analysis also showed that B. vulgaris leaf is rich in total phenol (0.91 g ascorbic acid equivalent / 100g dry weight) and total flavonoids (262.08 μg catechin equivalent/ g) (Table 1b) . These findings are consistent with the reports of Wele et al., (2017) , Abdillah et al., (2015) and Wang et al., (2016) . Flavonoids are one of the major antimalarial natural products and have been published to exhibit promising results. The malarial parasite (MP) load and MP percent (%) of the treated groups reduced upon the administration of the extract in a dose-dependent manner (Table 2) . The antiplasmodial activity of the plant extract reported in this study may be due to interactions between one or more group of the phytochemicals present in the extract. Several class of phytochemicals have been described in the field of antiplasmodials such as terpenoids, alkaloids, phenolic compounds including flavonoids and quinones (Oliveira et al., 2009; Adeleke et al., 2014; Tonukari et al., 2015; Aganbi et al., 2017; Vats et al., 2011; Tanaka et al., 2011) . Donno et al. (2012) who reported on the antimalarial activity of Artemisia annua herbal tea and artemisinin. This reduction may be due the interaction of flavonoids and other secondary metabolites present in the extract. Prior to treatment of the infected mice, there was elevated levels of serum electrolytes (sodium, calcium, phosphorus and chloride), liver markers (ALT, AST, ALP and GGT), and renal indices (urea, creatinine and uric acids) of the mice when compared with the normal control.
This was used as a baseline upon treatment. However, upon treatment with the B. vulgaris aqueous extract, the activities of serum ALT, AST, ALP and GGT of the treated groups were significantly reduced in the treated groups (Tables 3a and 3b ) when compared with the untreated positive control group (P<0.05) and it followed a dose-dependent manner. This indicates a restoration of liver integrity. Liver organic molecules (TB and DB) reduced upon the administration of the extract indicating its hepatoprotective effect (Table 4a and 4b) (Somsak et al., 2015; Thiengsusuk et al., 2013; Zulkefli et al., 2013; Viriyavejakul et al., 2014) . Similarly, the levels of serum electrolytes (sodium, calcium, phosphorus and chloride) of the treated groups reduced significantly when compared with the positive control (untreated malarial group) (P<0.05) ( Table 4 ). This report is consistent with the work of Ajayi et al. (2017) . The marked reduction is an indication of the restoration of renal activities and follows a dose dependent manner.Serum urea, creatinine and uric acids which are biomarkers of renal damage of the respective treated groups were significantly reduced when correlated with the control groups (P<0.05) ( Table 5 ). This strongly indicates a state of renal restoration in the malaria-sick mice groups treated with the B. vulgaris leaf extract and is in line with the reports of Ajayi et al. (2017) and Anigboro (2017) .
In conclusion, aqueous leaf extract of Bambusa vulgaris reported in this study exhibited chemoprotective effect in malarial parasitized mice in a dose dependent manner and this could be attributed to its rich content of phytoconstituents, including flavonoids and phenols. The hepatoprotection and renal function restoration observed upon the administration of the plant extract indicate to a far reaching end that B. vulgaris leaf extract would be a promising natural antimalarial product devoid of side effects upon use, especially when administered within the dose range of 100 -200 mg/Kg body weight investigated in this study.
